UNLABELLED: Despite advances in our understanding of the ways in which nutrient oversupply and triacylglycerol (TAG) anabolism contribute to hepatic steatosis, little is known about the lipases responsible for regulating hepatic TAG turnover. Recent studies have identified adipose triglyceride lipase (ATGL) as a major lipase in adipose tissue, although its role in the liver is largely unknown. Thus, we tested the contribution of ATGL to hepatic lipid metabolism and signaling. Adenovirus-mediated knockdown of hepatic ATGL resulted in steatosis in mice and decreased hydrolysis of TAG in primary hepatocyte cultures and in vitro assays. In addition to altering TAG hydrolysis, ATGL was shown to play a significant role in partitioning hydrolyzed fatty acids between metabolic pathways. Although ATGL gain and loss of function did not alter hepatic TAG secretion, fatty acid oxidation was increased by ATGL overexpression and decreased by ATGL knockdown. The effects on fatty acid oxidation coincided with decreased expression of peroxisome proliferator-activated receptor α (PPAR-α) and its target genes in mice with suppressed hepatic ATGL expression. However, PPAR-α agonism was unable to normalize the effects of ATGL knockdown on PPAR-α target gene expression, and this suggests that ATGL influences PPAR-α activity independently of ligand-induced activation. CONCLUSION: Taken together, these data show that ATGL is a major hepatic TAG lipase that plays an integral role in fatty acid partitioning and signaling to control energy metabolism.
UNLABELLED: Despite advances in our understanding of the ways in which nutrient oversupply and triacylglycerol (TAG) anabolism contribute to hepatic steatosis, little is known about the lipases responsible for regulating hepatic TAG turnover. Recent studies have identified adipose triglyceride lipase (ATGL) as a major lipase in adipose tissue, although its role in the liver is largely unknown. Thus, we tested the contribution of ATGL to hepatic lipid metabolism and signaling. Adenovirus-mediated knockdown of hepatic ATGL resulted in steatosis in mice and decreased hydrolysis of TAG in primary hepatocyte cultures and in vitro assays. In addition to altering TAG hydrolysis, ATGL was shown to play a significant role in partitioning hydrolyzed fatty acids between metabolic pathways. Although ATGL gain and loss of function did not alter hepatic TAG secretion, fatty acid oxidation was increased by ATGL overexpression and decreased by ATGL knockdown. The effects on fatty acid oxidation coincided with decreased expression of peroxisome proliferator-activated receptor α (PPAR-α) and its target genes in mice with suppressed hepatic ATGL expression. However, PPAR-α agonism was unable to normalize the effects of ATGL knockdown on PPAR-α target gene expression, and this suggests that ATGL influences PPAR-α activity independently of ligand-induced activation. CONCLUSION: Taken together, these data show that ATGL is a major hepatic TAG lipase that plays an integral role in fatty acid partitioning and signaling to control energy metabolism.
Authors: Hideaki Miyoshi; James W Perfield; Sandra C Souza; Wen-Jun Shen; Hui-Hong Zhang; Zlatina S Stancheva; Fredric B Kraemer; Martin S Obin; Andrew S Greenberg Journal: J Biol Chem Date: 2006-11-18 Impact factor: 5.157
Authors: Björn Magnusson; Lennart Asp; Pontus Boström; Michel Ruiz; Pia Stillemark-Billton; Daniel Lindén; Jan Borén; Sven-Olof Olofsson Journal: Arterioscler Thromb Vasc Biol Date: 2006-04-20 Impact factor: 8.311
Authors: Nathan E Wolins; Benjamin K Quaynor; James R Skinner; Anatoly Tzekov; Michelle A Croce; Matthew C Gropler; Vijayalakshmi Varma; Aiwei Yao-Borengasser; Neda Rasouli; Philip A Kern; Brian N Finck; Perry E Bickel Journal: Diabetes Date: 2006-12 Impact factor: 9.461
Authors: Gerald F Watts; Juying Ji; Dick C Chan; Esther M M Ooi; Anthony G Johnson; Kerry-Anne Rye; P Hugh R Barrett Journal: Clin Sci (Lond) Date: 2006-09 Impact factor: 6.124
Authors: Ji Young Kim; Kristin Tillison; Jun-Ho Lee; David A Rearick; Cynthia M Smas Journal: Am J Physiol Endocrinol Metab Date: 2006-05-16 Impact factor: 4.310
Authors: Achim Lass; Robert Zimmermann; Guenter Haemmerle; Monika Riederer; Gabriele Schoiswohl; Martina Schweiger; Petra Kienesberger; Juliane G Strauss; Gregor Gorkiewicz; Rudolf Zechner Journal: Cell Metab Date: 2006-05 Impact factor: 27.287
Authors: Enhui Wei; Mustafa Alam; Fengcheng Sun; Luis B Agellon; Dennis E Vance; Richard Lehner Journal: J Lipid Res Date: 2007-09-18 Impact factor: 5.922
Authors: Puntipa Kwanyuen; Sam M Witherspoon; Don R Creech; Heidi M Colton; J Greg Falls; Neal F Cariello Journal: Int J Toxicol Date: 2006 Jan-Feb Impact factor: 2.032
Authors: Erin E Kershaw; Michael Schupp; Hong-Ping Guan; Noah P Gardner; Mitchell A Lazar; Jeffrey S Flier Journal: Am J Physiol Endocrinol Metab Date: 2007-09-11 Impact factor: 4.310
Authors: Traci A Czyzyk; Amparo Romero-Picó; John Pintar; Jaime H McKinzie; Matthias H Tschöp; Michael A Statnick; Ruben Nogueiras Journal: FASEB J Date: 2012-05-16 Impact factor: 5.191
Authors: Micah B Schott; Karuna Rasineni; Shaun G Weller; Ryan J Schulze; Arthur C Sletten; Carol A Casey; Mark A McNiven Journal: J Biol Chem Date: 2017-05-17 Impact factor: 5.157
Authors: L Nikolaenko; Y Jia; C Wang; M Diaz-Arjonilla; J K Yee; S W French; P Y Liu; S Laurel; C Chong; K Lee; Y Lue; W N P Lee; R S Swerdloff Journal: Endocrinology Date: 2013-11-26 Impact factor: 4.736